Breathing training from home shows promise for DMD children
NCT ID NCT07172737
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether breathing muscle exercises done at home via video calls could improve lung function and quality of life in 40 children with Duchenne muscular dystrophy. The children, aged 5-17, used a device to strengthen their breathing muscles. Researchers measured changes in breathing strength and daily breathlessness. The goal is to find a simple, accessible way to help manage respiratory problems in DMD.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Functional inspiratory muscle training via tele-rehabilitation
- What this could lead to
- If it works, this could offer a convenient home-based way to help children with Duchenne muscular dystrophy breathe easier and improve daily life.
- What could go wrong
- This is a small, completed study with only 40 participants. Results may not apply to all children with DMD, and the benefits might be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tepecik training and research hospital
Izmir, Konak, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a lower steroid dose preserve strength in young boys with DMD?
- Can a targeted infusion slow muscle decline in duchenne? a new trial aims to find out.
- Can a massive patient database unlock new treatments for muscular dystrophy?
- Umbilical cord stem cells aim to slow muscle loss in duchenne boys
- Experimental drug aims to preserve arm and lung function in boys with advanced duchenne
- Experimental drug KER-065 aims to slow muscle decline in duchenne muscular dystrophy